• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用受试者工作特征曲线分析确定最佳催乳素阈值以确定催乳素瘤大小。

Identification of an optimal prolactin threshold to determine prolactinoma size using receiver operating characteristic analysis.

机构信息

Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism (WISDEM), University Hospitals Coventry and Warwickshire NHS Trust, Coventry, CV2 2DX, UK.

1st Department of Propaedeutic Internal Medicine, Endocrine Unit, National and Kapodistrian, University of Athens, 11527, Athens, Greece.

出版信息

Sci Rep. 2021 May 7;11(1):9801. doi: 10.1038/s41598-021-89256-7.

DOI:10.1038/s41598-021-89256-7
PMID:33963239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8105338/
Abstract

Prolactinomas represent the most common type of secretory pituitary neoplasms, with a therapeutic management that varies considerably based on tumour size and degree of hyperprolactinemia. The aim of the current study was to evaluate the relationship between serum prolactin (PRL) concentrations and prolactinoma size, and to determine a cut-off PRL value that could differentiate micro- from macro-prolactinomas. A retrospective cohort study of 114 patients diagnosed with prolactinomas between 2007 and 2017 was conducted. All patients underwent gadolinium enhanced pituitary MRI and receiver operating characteristic (ROC) analyses were performed. 51.8% of patients in this study were men, with a mean age at the time of diagnosis of 42.32 ± 15.04 years. 48.2% of the total cohort were found to have microadenomas. Baseline serum PRL concentrations were strongly correlated to tumour dimension (r = 0.750, p = 0.001). When performing the ROC curve analysis, the area under the curve was 0.976, indicating an excellent accuracy of the diagnostic method. For a value of 204 μg/L (4338 mU/L), sensitivity and specificity were calculated at 0.932 and 0.891, respectively. When a cut off value of 204 μg/L (4338 mU/L) was used, specificity was 93.2%, and sensitivity 89.1%, acceptable to reliably differentiate between micro- and macro- adenomas.

摘要

催乳素瘤是最常见的分泌性垂体肿瘤,其治疗管理因肿瘤大小和高催乳素血症程度而异。本研究旨在评估血清催乳素(PRL)浓度与催乳素瘤大小之间的关系,并确定一个区分微腺瘤和大腺瘤的 PRL 截止值。对 2007 年至 2017 年间诊断为催乳素瘤的 114 例患者进行了回顾性队列研究。所有患者均接受钆增强垂体 MRI 检查,并进行了受试者工作特征(ROC)分析。本研究中 51.8%的患者为男性,诊断时的平均年龄为 42.32±15.04 岁。总队列中有 48.2%的患者被发现为微腺瘤。基线血清 PRL 浓度与肿瘤大小呈强相关(r=0.750,p=0.001)。进行 ROC 曲线分析时,曲线下面积为 0.976,表明诊断方法具有极好的准确性。当 204μg/L(4338mU/L)为截断值时,灵敏度和特异性分别为 0.932 和 0.891。当使用 204μg/L(4338mU/L)的截断值时,特异性为 93.2%,灵敏度为 89.1%,可可靠地区分微腺瘤和大腺瘤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4718/8105338/1982e066fcab/41598_2021_89256_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4718/8105338/406b0765ab8d/41598_2021_89256_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4718/8105338/5d70f5961d50/41598_2021_89256_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4718/8105338/6f1c1caa2352/41598_2021_89256_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4718/8105338/f467a0be982a/41598_2021_89256_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4718/8105338/1982e066fcab/41598_2021_89256_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4718/8105338/406b0765ab8d/41598_2021_89256_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4718/8105338/5d70f5961d50/41598_2021_89256_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4718/8105338/6f1c1caa2352/41598_2021_89256_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4718/8105338/f467a0be982a/41598_2021_89256_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4718/8105338/1982e066fcab/41598_2021_89256_Fig5_HTML.jpg

相似文献

1
Identification of an optimal prolactin threshold to determine prolactinoma size using receiver operating characteristic analysis.应用受试者工作特征曲线分析确定最佳催乳素阈值以确定催乳素瘤大小。
Sci Rep. 2021 May 7;11(1):9801. doi: 10.1038/s41598-021-89256-7.
2
Hormone levels and tumour size response to quinagolide and cabergoline in patients with prolactin-secreting and clinically non-functioning pituitary adenomas: predictive value of pituitary scintigraphy with 123I-methoxybenzamide.分泌催乳素和临床无功能垂体腺瘤患者中激素水平及肿瘤大小对喹高利特和卡麦角林的反应:123I-甲氧基苄胺垂体闪烁显像的预测价值
Clin Endocrinol (Oxf). 2000 Apr;52(4):437-45. doi: 10.1046/j.1365-2265.2000.00951.x.
3
The value of prolactin in predicting prolactinοma in hyperprolactinaemic polycystic ovarian syndrome.催乳素在高催乳素血症多囊卵巢综合征中预测催乳素瘤的价值。
Eur J Clin Invest. 2018 Jul;48(7):e12961. doi: 10.1111/eci.12961. Epub 2018 Jun 13.
4
Tumor volume improves preoperative differentiation of prolactinomas and nonfunctioning pituitary adenomas.肿瘤体积有助于术前鉴别泌乳素瘤和无功能垂体腺瘤。
Endocrine. 2021 Oct;74(1):138-145. doi: 10.1007/s12020-021-02744-8. Epub 2021 May 8.
5
Serum Prolactin Level to Tumor Size Ratio as a Potential Parameter for Preoperative Differentiation of Prolactinomas from Hyperprolactinemia-Causing Non-functional Pituitary Adenomas.血清催乳素水平与肿瘤大小比值作为催乳素瘤与引起高催乳素血症的无功能垂体腺瘤术前鉴别诊断的一个潜在参数。
World Neurosurg. 2022 Mar;159:e488-e496. doi: 10.1016/j.wneu.2021.12.074. Epub 2021 Dec 25.
6
Magnetic resonance imaging in the management of prolactinomas; a review of the evidence.磁共振成像在泌乳素瘤管理中的应用:证据回顾。
Pituitary. 2020 Feb;23(1):16-26. doi: 10.1007/s11102-019-01001-6.
7
The outcome of hypophysectomy for prolactinomas in the era of dopamine agonist therapy.多巴胺激动剂治疗时代泌乳素瘤垂体切除术的结果
Clin Endocrinol (Oxf). 1996 Jun;44(6):711-6. doi: 10.1046/j.1365-2265.1996.738559.x.
8
Is a stable or decreasing prolactin level in a patient with prolactinoma a surrogate marker for lack of tumor growth?对于泌乳素瘤患者,泌乳素水平稳定或下降是否是肿瘤生长缺乏的替代标志物?
Pituitary. 2014 Apr;17(2):97-102. doi: 10.1007/s11102-013-0473-5.
9
Falsely low serum prolactin in two cases of invasive macroprolactinoma.两例侵袭性大泌乳素瘤患者血清泌乳素假性降低
Pituitary. 2002;5(4):261-5. doi: 10.1023/a:1025334001748.
10
The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas.两种选择性2型多巴胺受体激动剂喹高利特和卡麦角林在治疗泌乳素瘤中的作用。
Clin Endocrinol (Oxf). 2000 Jul;53(1):53-60. doi: 10.1046/j.1365-2265.2000.01016.x.

引用本文的文献

1
The Influence of Pituitary Morphology on the Occurrence of Hormonal Disorders in Patients with Empty Sella or Partial Empty Sella.垂体形态对空蝶鞍或部分空蝶鞍患者激素紊乱发生的影响。
Biomedicines. 2025 Mar 21;13(4):762. doi: 10.3390/biomedicines13040762.
2
Relationship Between Radiological Features of Primary Empty or Primary Partial Empty Sella and Pituitary Hormone Levels.原发性空蝶鞍或原发性部分空蝶鞍的影像学特征与垂体激素水平的关系。
Biomedicines. 2025 Mar 15;13(3):722. doi: 10.3390/biomedicines13030722.
3
Gender differences in prolactin thresholds and their association with lactotroph adenoma invasiveness for potential treatment considerations.

本文引用的文献

1
Hyperprolactinaemia.高催乳素血症
J Clin Med. 2019 Dec 13;8(12):2203. doi: 10.3390/jcm8122203.
2
Prolactinomas and nonfunctioning adenomas: preoperative diagnosis of tumor type using serum prolactin and tumor size.催乳素瘤和无功能腺瘤:利用血清催乳素和肿瘤大小进行肿瘤类型的术前诊断
J Neurosurg. 2019 Jun 14;133(2):321-328. doi: 10.3171/2019.3.JNS19121. Print 2020 Aug 1.
3
Echocardiography and monitoring patients receiving dopamine agonist therapy for hyperprolactinaemia: A joint position statement of the British Society of Echocardiography, the British Heart Valve Society and the Society for Endocrinology.
催乳素阈值的性别差异及其与催乳素瘤侵袭性的关联,以供潜在治疗考虑。
Sci Rep. 2025 Mar 20;15(1):9598. doi: 10.1038/s41598-025-90250-6.
4
Recovery of hypopituitarism in macroprolactinomas: a comparison of medical vs. surgical treatment. Results from a European multicenter study.大泌乳素瘤患者垂体功能减退的恢复:药物治疗与手术治疗的比较。一项欧洲多中心研究的结果
J Endocrinol Invest. 2025 Mar 4. doi: 10.1007/s40618-025-02559-8.
5
Correlation between MRI findings of pituitary gland and prolactin level among hyperprolactinemia adult female Saudi patients in rural areas: A retrospective multicentric study.沙特农村地区成年女性高泌乳素血症患者垂体MRI表现与泌乳素水平的相关性:一项回顾性多中心研究
Medicine (Baltimore). 2025 Jan 10;104(2):e40686. doi: 10.1097/MD.0000000000040686.
6
Breast Cancer risk in patients with dopamine agonist-treated hyperprolactinemia.多巴胺激动剂治疗的高泌乳素血症患者的乳腺癌风险
J Endocrinol Invest. 2025 Mar;48(3):691-699. doi: 10.1007/s40618-024-02492-2. Epub 2024 Oct 30.
7
Prolactinoma: Navigating the Dual Challenge of Side Effects and Treatment Strategies - A Comprehensive Review.泌乳素瘤:应对副作用与治疗策略的双重挑战——全面综述
Ann Med Surg (Lond). 2024 Jun 21;86(8):4613-4623. doi: 10.1097/MS9.0000000000002308. eCollection 2024 Aug.
8
Gender-specific prolactin thresholds to determine prolactinoma size: a novel Bayesian approach and its clinical utility.用于确定泌乳素瘤大小的性别特异性泌乳素阈值:一种新型贝叶斯方法及其临床应用。
Front Surg. 2024 Mar 13;11:1363431. doi: 10.3389/fsurg.2024.1363431. eCollection 2024.
9
Cabergoline Failure and a Spontaneous Pregnancy in a Microprolactinoma with High Prolactin Levels.卡麦角林治疗失败及高催乳素水平的微泌乳素瘤患者自然受孕
J Pers Med. 2022 Dec 14;12(12):2061. doi: 10.3390/jpm12122061.
10
Diagnostic criteria of small sellar lesions with hyperprolactinemia: Prolactinoma or else.伴有高泌乳素血症的鞍内小病灶的诊断标准:泌乳素瘤还是其他疾病。
Front Endocrinol (Lausanne). 2022 Sep 6;13:901385. doi: 10.3389/fendo.2022.901385. eCollection 2022.
超声心动图与多巴胺激动剂治疗高泌乳素血症患者的监测:英国超声心动图学会、英国心脏瓣膜学会和内分泌学会联合立场声明。
Clin Endocrinol (Oxf). 2019 May;90(5):662-669. doi: 10.1111/cen.13940. Epub 2019 Feb 28.
4
Prolactin Biology and Laboratory Measurement: An Update on Physiology and Current Analytical Issues.催乳素生物学与实验室检测:生理学及当前分析问题的最新进展
Clin Biochem Rev. 2018 Feb;39(1):3-16.
5
Controversial issues in the management of hyperprolactinemia and prolactinomas - An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism.高催乳素血症和催乳素瘤管理中的争议问题——巴西内分泌与代谢学会神经内分泌学部门概述
Arch Endocrinol Metab. 2018 Mar-Apr;62(2):236-263. doi: 10.20945/2359-3997000000032.
6
Prolactinomas.催乳素瘤
Endocrinol Metab Clin North Am. 2015 Mar;44(1):71-8. doi: 10.1016/j.ecl.2014.11.003. Epub 2014 Nov 6.
7
Diagnostic pitfalls of hyperprolactinemia: the importance of sequential pituitary imaging.高催乳素血症的诊断陷阱:序贯垂体成像的重要性
BMC Res Notes. 2014 Aug 20;7:555. doi: 10.1186/1756-0500-7-555.
8
Prolactin levels and gender are associated with tumour behaviour in prolactinomas but Ki-67 index is not.催乳素水平和性别与催乳素瘤的肿瘤行为相关,但Ki-67指数与之无关。
Endokrynol Pol. 2014;65(3):210-6. doi: 10.5603/EP.2014.0029.
9
Importance of cannulated prolactin test in the definition of hyperprolactinaemia.经导管催乳素检测在高催乳素血症定义中的重要性。
Pituitary. 2015 Jun;18(3):319-25. doi: 10.1007/s11102-014-0576-7.
10
Hypopituitarism patterns and prevalence among men with macroprolactinomas.大泌乳素瘤男性患者的垂体功能减退模式及患病率
Pituitary. 2015 Feb;18(1):108-15. doi: 10.1007/s11102-014-0563-z.